Newsletter | July 1, 2020

07.01.20 -- Navigating The Landscape Of Biologics Development And Manufacturing

Beyond COVID-19: How Localization Can Strengthen Supply Chains

The coronavirus pandemic has already changed the way industry looks at localization and forming resilient supply chain capabilities. In the current climate, not having local capabilities could shutter your business.

It Depends: The Real Answer To The Single-Use Or Stainless-Steel Question

During the past decade there have been innumerable and contentious comparisons between stainless-steel and single-use (SU) biomanufacturing systems. The reality is that stainless steel and SU can coexist — and often do — in today’s hybrid bioprocessing manufacturing environments.

Key Considerations To Ensure A Successful Drug Substance Transfer

Getting ready to scale up or migrate your bioprocessing? This white paper covers important steps you should take to ensure a successful drug substance technology transfer.

Biopharmaceutical Process Characterization

Process development and characterization strategies are required to support the commercial-scale manufacture of antibody therapeutics. View this webinar to learn what is required to develop a scalable  manufacturing process to support the successful GMP manufacture of biologics.

Contract Manufacturing

Samsung Biologics is a reliable partner for seamless tech transfers, clinical and commercial manufacturing, aseptic fill/finish and analytical testing. From the beginning of our partnership, you will have a dedicated project management team to walk you through the entire journey of the product development and manufacturing of your product. We are committed to operational excellence in cGMP manufacturing and quality assurance to deliver value to our clients.

Request Information